[CTSO] Cytosorbents Corporation

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 5.5 Change: 0.1 (1.85%)
Ext. hours: Change: 0 (0%)

chart CTSO

Refresh chart

Strongest Trends Summary For CTSO

CTSO is in the medium-term down -46% below S&P in 1 year. In the long-term down -49% in 1 year.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -29.46% Sales Growth - Q/Q-17.28% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-82.35% ROE-135.15% ROI
Current Ratio2.4 Quick Ratio2.29 Long Term Debt/Equity Debt Ratio0.64
Gross Margin53.09% Operating Margin-233.51% Net Profit Margin-345.24% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities10.01 M Cash From Investing Activities-1.13 M Cash From Operating Activities-2.41 M Gross Profit420 K
Net Profit-4.72 M Operating Profit-2.71 M Total Assets15.86 M Total Current Assets14.88 M
Total Current Liabilities6.2 M Total Debt Total Liabilities6.2 M Total Revenue720 K
Technical Data
High 52 week14.8 Low 52 week6.48 Last close6.91 Last change-3.63%
RSI43.55 Average true range0.44 Beta1.77 Volume10 K
Simple moving average 20 days-2.55% Simple moving average 50 days-6.15% Simple moving average 200 days-26.66%
Performance Data
Performance Week6.14% Performance Month-1.85% Performance Quart-16.55% Performance Half-28.62%
Performance Year-23.22% Performance Year-to-date-14.48% Volatility daily3.66% Volatility weekly8.18%
Volatility monthly16.76% Volatility yearly58.08% Relative Volume219.85% Average Volume129.33 K
New High New Low

News

2019-10-11 06:59:13 | Is Cytosorbents Corporation's NASDAQ:CTSO CEO Salary Justified?

2019-10-10 07:00:00 | CytoSorbents to Present at The MicroCap Rodeo Investor Conference

2019-10-04 07:08:00 | CytoSorb® Removal of Ticagrelor Intraoperatively Results in Projected Cost Savings of Approximately $5,000 in Each Patient Undergoing Emergency Cardiac Surgery

2019-10-02 08:24:00 | CytoSorbents Announces Positive Surgical Outcomes From CytoSorb Removal Of Antithrombotics In Emergency Cardiothoracic Surgery

2019-09-25 06:58:00 | CytoSorbents Highlights Survival Benefit of CytoSorb Therapy in Septic Shock

2019-09-21 08:44:45 | Analysts Expect Breakeven For Cytosorbents Corporation NASDAQ:CTSO

2019-09-19 10:15:00 | MicroCap Rodeo Investor Conference - October 15 and 16, 2019, Austin Texas

2019-09-16 07:00:00 | First Study to Evaluate CytoSorb in Cytokine Release Syndrome CRS Following CAR T-cell Immunotherapy to Commence

2019-09-13 07:08:00 | World Sepsis Day 2019: CytoSorbents Highlights Its Support of Multiple Organizations In the Fight Against Sepsis

2019-09-09 07:00:00 | CytoSorbents to Present at the H.C. Wainwright 21st Annual Global Investment Conference

2019-08-28 09:51:00 | CytoSorbents Highlights Recent Published Studies on CytoSorb

2019-08-26 07:18:36 | With A -17% Earnings Drop, Is Cytosorbents Corporation's NASDAQ:CTSO A Concern?

2019-08-22 09:45:00 | CTSO: Q2 19: Product Sales Rebound to Record High Despite Distributor Hangover. Value-Inflection Opportunities Abound

2019-08-15 13:54:00 | CytoSorbents Receives Renewal of CytoSorb® CE Mark Through May 2024 and Annual ISO 13485:2016 Certification Through September 2022

2019-08-13 07:08:00 | CytoSorbents Expands CytoSorb Distribution in Latin America to Brazil, Colombia, and Costa Rica

2019-08-07 21:24:51 | Cytosorbents CTSO Q2 2019 Earnings Call Transcript

2019-08-06 16:15:00 | CytoSorbents Reports Record Second Quarter 2019 Financial Results

2019-08-05 17:00:00 | CytoSorbents Announces Amendment to Loan Agreement with Bridge Bank, Receives an Additional $5 Million Cash from New Term Loan

2019-08-01 11:34:18 | The Cytosorbents NASDAQ:CTSO Share Price Is Down 46% So Some Shareholders Are Getting Worried

2019-07-30 07:00:00 | CytoSorbents to Report Q2 2019 Operating and Financial Results

2019-06-26 15:25:32 | Do Insiders Own Shares In Cytosorbents Corporation NASDAQ:CTSO?

2019-06-18 06:30:00 | CytoSorbents to Present at the Raymond James Life Sciences and MedTech Conference

2019-06-11 07:00:00 | CytoSorbents to Present at the Three Part Advisors 2019 East Coast IDEAS Investor Conference

2019-06-07 07:48:17 | Does Market Volatility Impact Cytosorbents Corporation's NASDAQ:CTSO Share Price?

2019-06-03 07:00:00 | CytoSorbents to Present at the Jefferies 2019 Global Healthcare Conference

2019-05-20 07:00:00 | CytoSorbents to Participate at the B. Riley FBR 20th Annual Institutional Investor Conference

2019-05-09 15:30:00 | CTSO: Distributor Sales Take a Breather But Expected to Rebound. Direct Sales Remain Robust

2019-05-07 19:33:24 | CytoSorbents: 1Q Earnings Snapshot

2019-05-07 16:15:00 | CytoSorbents Reports First Quarter 2019 Financial Results and Provides Second Quarter 2019 Guidance

2019-05-01 07:00:00 | CytoSorbents to Report Q1 2019 Operating and Financial Results

2019-04-24 07:08:00 | CytoSorbents Highlights the 6th International CytoSorb Users' Meeting and Recent Activities at the 2019 ISICEM and EuroELSO Conferences

2019-04-08 05:30:00 | CytoSorbents to Present at the H.C. Wainwright Global Life Sciences Conference 2019 London

2019-03-25 07:10:00 | Israel Approves CytoSorb Registration, CytoSorbents Announces Gad Medical as Distributor

2019-03-11 16:20:00 | CTSO: Q4 2018: Product Sales +27%, Expenses Jump In Part Due to Investments Aimed at Further Accelerating Growth

2019-03-07 22:00:00 | Cytosorbents Corp CTSO Q4 2018 Earnings Conference Call Transcript

2019-03-07 16:15:00 | CytoSorbents Achieves Record Revenue and Product Sales Growth in 2018

2019-03-06 07:00:00 | CytoSorbents to Present at the Cowen 39th Annual Health Care Conference

2019-03-05 07:10:00 | CytoSorbents Expands Direct Sales to Poland, the Nordics, and the Netherlands

2019-02-28 07:00:00 | CytoSorbents to Report Fiscal 2018 Operating and Financial Results

2019-02-25 07:08:00 | CytoSorbents to Participate at the 8th Annual SVB Leerink Global Healthcare Conference

2019-02-05 07:00:00 | CytoSorbents to Present at the 21st Annual BIO CEO & Investor Conference

2019-02-04 15:00:00 | CTSO: DSMB Recommends Continuance of REMOVE Study: Has several important implications

2019-02-04 06:58:00 | CytoSorbents Announces the Data Safety Monitoring Board Recommends Continuation of REMOVE Endocarditis Trial

2019-02-01 11:30:00 | LD Micro Welcomes Nearly 1,000 Companies to the LD Micro Index

2019-01-23 07:45:00 | Detailed Research: Economic Perspectives on Shell Midstream Partners, Interface, National Western Life Group, TPG Specialty Lending, Francesca's, and Cytosorbents — What Drives Growth in Today's Competitive Landscape

2019-01-22 07:08:00 | CytoSorbents Announces Expansion of CytoSorb® Partnership with Fresenius Medical Care

2019-01-18 14:22:59 | Is Cytosorbents Corporation’s NASDAQ:CTSO CEO Pay Fair?

2019-01-07 15:45:00 | CTSO: Q4 / FY 2018: Record Product Sales in Q4, Jumps 51% in 2018

2019-01-07 09:20:00 | CytoSorbents Issues Stockholder Letter with Preliminary 2018 Financial Results

2019-01-04 07:00:00 | CytoSorbents To Highlight Progress at Biotech Showcase 2019